$510,000 of ACADIA PHARMACEUTICALS lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Implementation of the Inflation Reduction Act of 2022; Issues Related to the Orphan Drug Tax Credit; Help Copays Act (HR 830 / S 1375); Orphan Cures Act (HR 5539 / S 3131); National Plan to End Parkinson's Act (HR 2365 / S 1064); Protect Rare Act (HR 6094); The Creating Hope Reauthorization Act (HR 7384 / S 4583) / HR 3433); BIOSECURE Act (HR 7085); The American Recovery Act (HR 10545). Implementation of the Inflation Reduction Act of 2022; Issues related to protecting patient access to medicines in Medicare; Issues related to access to medicines for Parkinson's disease patients; Issues Related to Antipsychotic use in Medicaid (HR 4096); Orphan Cures Act (HR 5539 / S 3131); National Plan to End Parkinson's Act (HR 2365 / S 1064); Protect Rare Act (HR 6094); EPIC Act (HR 7174); BIOSECURE Act (HR 7085); The Mini Act (HR 5547 / S 476). BIOSECURE Act (HR 7085). Issues related to the Orphan Drug Tax Credit."
You can find more data on corporate lobbying on Quiver Quantitative.
ACAD Insider Trading Activity
ACAD insiders have traded $ACAD stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $ACAD stock by insiders over the last 6 months:
- STEPHEN DAVIS (CEO) sold 31,747 shares for an estimated $485,094
- MARK C. SCHNEYER (EVP, CHIEF FINANCIAL OFFICER) has made 0 purchases and 2 sales selling 19,992 shares for an estimated $321,174.
- BRENDAN TEEHAN (EVP, COO, HEAD OF COMMERCIAL) has made 0 purchases and 2 sales selling 19,863 shares for an estimated $319,310.
- JAMES KIHARA (PRINCIPAL ACCOUNTING OFFICER) sold 4,073 shares for an estimated $68,467
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ACAD Hedge Fund Activity
We have seen 123 institutional investors add shares of ACAD stock to their portfolio, and 122 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. removed 3,710,140 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $57,061,953
- FMR LLC removed 2,269,618 shares (-95.9%) from their portfolio in Q3 2024, for an estimated $34,906,724
- SG AMERICAS SECURITIES, LLC added 1,966,607 shares (+380.3%) to their portfolio in Q4 2024, for an estimated $36,087,238
- MARSHALL WACE, LLP removed 1,585,741 shares (-57.2%) from their portfolio in Q3 2024, for an estimated $24,388,696
- ECOR1 CAPITAL, LLC removed 1,346,475 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $20,708,785
- MAN GROUP PLC added 1,218,288 shares (+2131.9%) to their portfolio in Q3 2024, for an estimated $18,737,269
- NUVEEN ASSET MANAGEMENT, LLC added 921,136 shares (+208.5%) to their portfolio in Q3 2024, for an estimated $14,167,071
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
